QR kód

Case Report: Immune checkpoint inhibitor plus chemotherapy benefited an elderly patient with non-small cell lung cancer following EGFR-TKI resistance

Renal metastasis from non-small cell lung cancer (NSCLC) is uncommon. This report describes an elderly patient with EGFR-mutant NSCLC and high PD-L1 expression (TPS 70%). Following six months of targeted therapy, the renal lesion increased in size compared to baseline. Although the patient remained...

Celý popis

Uloženo v:
Hlavní autoři: Zhiyu Liu, Chenchen Wei, Chongguo Zhang, Zhaoxia Wang
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2026-05-01
Edice:Frontiers in Oncology
Témata:
chemotherapy
drug resistance
EGFR-positive
immunotherapy
NSCLC
renal metastasis
On-line přístup:https://www.frontiersin.org/articles/10.3389/fonc.2026.1825651/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky